Mutations in APP, PSEN1, and PSEN2 genes modify size and biochemical profiles of Aβ peptides generated from APP. The authors have shown that familial AD cases also show a distinctive Aβ peptide signature in CAA deposits when compared with those from sporadic AD cases.142. This evidence concerns the gene APP and Alzheimer disease.